Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study

Overview of attention for article published in BMC Infectious Diseases, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 28 X posts from 25 X users, with an upper bound of 169,572 followers.

RT @BioMedCentral: Research published in #BMCInfectDis found that convalescent plasma treatment reduces hospital length of stay but not SAR…

RT @BioMedCentral: Research published in #BMCInfectDis found that convalescent plasma treatment reduces hospital length of stay but not SAR…

RT @BioMedCentral: Research published in #BMCInfectDis found that convalescent plasma treatment reduces hospital length of stay but not SAR…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 24 additional X posts.